CN105785033A - 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 - Google Patents
基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 Download PDFInfo
- Publication number
- CN105785033A CN105785033A CN201610176054.2A CN201610176054A CN105785033A CN 105785033 A CN105785033 A CN 105785033A CN 201610176054 A CN201610176054 A CN 201610176054A CN 105785033 A CN105785033 A CN 105785033A
- Authority
- CN
- China
- Prior art keywords
- fetoprotein
- alpha
- nucleic acid
- acid aptamer
- fluorescence probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 26
- 102000004641 Fetal Proteins Human genes 0.000 title claims abstract description 23
- 108010003471 Fetal Proteins Proteins 0.000 title claims abstract description 23
- 238000001514 detection method Methods 0.000 title claims abstract description 23
- 239000007850 fluorescent dye Substances 0.000 title abstract description 4
- 239000000523 sample Substances 0.000 claims abstract description 131
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 49
- 210000004369 blood Anatomy 0.000 claims abstract description 41
- 239000008280 blood Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 16
- 102000013529 alpha-Fetoproteins Human genes 0.000 claims description 124
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 124
- 108091008104 nucleic acid aptamers Proteins 0.000 claims description 64
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims description 42
- 238000012360 testing method Methods 0.000 claims description 30
- 230000005284 excitation Effects 0.000 claims description 28
- 102000002322 Egg Proteins Human genes 0.000 claims description 23
- 108010000912 Egg Proteins Proteins 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 23
- 210000004681 ovum Anatomy 0.000 claims description 23
- 239000012530 fluid Substances 0.000 claims description 22
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims description 21
- 239000008363 phosphate buffer Substances 0.000 claims description 19
- 239000000178 monomer Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000005336 cracking Methods 0.000 claims description 12
- 239000000539 dimer Substances 0.000 claims description 11
- 210000005259 peripheral blood Anatomy 0.000 claims description 11
- 239000011886 peripheral blood Substances 0.000 claims description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 10
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 10
- 239000007983 Tris buffer Substances 0.000 claims description 10
- 239000003146 anticoagulant agent Substances 0.000 claims description 10
- 229940127219 anticoagulant drug Drugs 0.000 claims description 10
- 230000005281 excited state Effects 0.000 claims description 10
- 229960002897 heparin Drugs 0.000 claims description 10
- 229920000669 heparin Polymers 0.000 claims description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 10
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 11
- 210000003743 erythrocyte Anatomy 0.000 abstract description 10
- 239000008055 phosphate buffer solution Substances 0.000 abstract 2
- 239000008004 cell lysis buffer Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 9
- 229910021642 ultra pure water Inorganic materials 0.000 description 9
- 239000012498 ultrapure water Substances 0.000 description 9
- 102000003929 Transaminases Human genes 0.000 description 5
- 108090000340 Transaminases Proteins 0.000 description 5
- 210000004381 amniotic fluid Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 201000010829 Spina bifida Diseases 0.000 description 2
- 208000006097 Spinal Dysraphism Diseases 0.000 description 2
- 206010002320 anencephaly Diseases 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 241000158541 Syntrophus <bacteria> Species 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 201000000053 blastoma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000008184 embryoma Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (9)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710721400.5A CN107561286A (zh) | 2016-03-25 | 2016-03-25 | 一种高灵敏度的甲胎蛋白试剂盒 |
CN201710721244.2A CN107561284B (zh) | 2016-03-25 | 2016-03-25 | 易于操作的甲胎蛋白试剂盒 |
CN201710721331.8A CN107561285B (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN201610176054.2A CN105785033B (zh) | 2016-03-25 | 2016-03-25 | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 |
CN201710721377.XA CN107576801A (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610176054.2A CN105785033B (zh) | 2016-03-25 | 2016-03-25 | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710721377.XA Division CN107576801A (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN201710721400.5A Division CN107561286A (zh) | 2016-03-25 | 2016-03-25 | 一种高灵敏度的甲胎蛋白试剂盒 |
CN201710721244.2A Division CN107561284B (zh) | 2016-03-25 | 2016-03-25 | 易于操作的甲胎蛋白试剂盒 |
CN201710721331.8A Division CN107561285B (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105785033A true CN105785033A (zh) | 2016-07-20 |
CN105785033B CN105785033B (zh) | 2017-10-31 |
Family
ID=56391489
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710721331.8A Active CN107561285B (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN201710721377.XA Pending CN107576801A (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN201610176054.2A Active CN105785033B (zh) | 2016-03-25 | 2016-03-25 | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 |
CN201710721400.5A Pending CN107561286A (zh) | 2016-03-25 | 2016-03-25 | 一种高灵敏度的甲胎蛋白试剂盒 |
CN201710721244.2A Active CN107561284B (zh) | 2016-03-25 | 2016-03-25 | 易于操作的甲胎蛋白试剂盒 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710721331.8A Active CN107561285B (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN201710721377.XA Pending CN107576801A (zh) | 2016-03-25 | 2016-03-25 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710721400.5A Pending CN107561286A (zh) | 2016-03-25 | 2016-03-25 | 一种高灵敏度的甲胎蛋白试剂盒 |
CN201710721244.2A Active CN107561284B (zh) | 2016-03-25 | 2016-03-25 | 易于操作的甲胎蛋白试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN107561285B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106501226A (zh) * | 2016-10-17 | 2017-03-15 | 柳州立洁科技有限公司 | 利用兴奋剂核酸适体epo5的兴奋剂试剂盒及其检测方法 |
CN106525784A (zh) * | 2016-10-17 | 2017-03-22 | 柳州立洁科技有限公司 | 基于核酸适体荧光探针ins5胰岛素试剂盒及其检测方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108956573A (zh) * | 2018-08-02 | 2018-12-07 | 重庆医科大学附属儿童医院 | 一种检测xiap蛋白的试剂盒及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102732606A (zh) * | 2012-02-27 | 2012-10-17 | 南昌大学 | 基于核酸适配子的肝癌诊断试剂盒 |
US20140106370A1 (en) * | 2008-12-02 | 2014-04-17 | Industrial Technology Research Institute | Biomakers useful in liver fibrosis diagnosis |
CN104131105A (zh) * | 2014-08-11 | 2014-11-05 | 复旦大学附属中山医院 | 一种特异性结合甲胎蛋白核酸适配体的筛选方法 |
CN104360085A (zh) * | 2014-12-05 | 2015-02-18 | 重庆乾德生物技术有限公司 | 一种afp检测试剂盒 |
CN104597246A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 |
EP2921857A1 (en) * | 2014-03-18 | 2015-09-23 | Medizinische Universität Wien | Soluble AXL receptor tyrosine kinase in the diagnosis of cancer |
CN104931478A (zh) * | 2015-06-11 | 2015-09-23 | 江南大学 | 基于银纳米粒子三聚体的表面增强拉曼散射效应超灵敏检测甲胎蛋白的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101513766B1 (ko) * | 2011-02-14 | 2015-04-20 | 충북대학교 산학협력단 | 알파태아단백질에 특이적으로 결합하는 dna 앱타머 및 이의 용도 |
KR101520615B1 (ko) * | 2013-03-20 | 2015-05-18 | 서울대학교산학협력단 | 간암 진단용 바이오 마커 |
WO2015164364A2 (en) * | 2014-04-25 | 2015-10-29 | The Brigham And Women's Hospital, Inc. | Methods to manipulate alpha-fetoprotein (afp) |
KR101670135B1 (ko) * | 2014-10-30 | 2016-10-27 | 충북대학교 산학협력단 | 리포칼린 2 단백질에 특이적으로 결합하는 dna 앱타머 및 이의 용도 |
EP3253414A4 (en) * | 2015-02-05 | 2018-07-11 | The University Of Queensland | Targeting constructs for delivery of payloads |
-
2016
- 2016-03-25 CN CN201710721331.8A patent/CN107561285B/zh active Active
- 2016-03-25 CN CN201710721377.XA patent/CN107576801A/zh active Pending
- 2016-03-25 CN CN201610176054.2A patent/CN105785033B/zh active Active
- 2016-03-25 CN CN201710721400.5A patent/CN107561286A/zh active Pending
- 2016-03-25 CN CN201710721244.2A patent/CN107561284B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140106370A1 (en) * | 2008-12-02 | 2014-04-17 | Industrial Technology Research Institute | Biomakers useful in liver fibrosis diagnosis |
CN102732606A (zh) * | 2012-02-27 | 2012-10-17 | 南昌大学 | 基于核酸适配子的肝癌诊断试剂盒 |
EP2921857A1 (en) * | 2014-03-18 | 2015-09-23 | Medizinische Universität Wien | Soluble AXL receptor tyrosine kinase in the diagnosis of cancer |
CN104131105A (zh) * | 2014-08-11 | 2014-11-05 | 复旦大学附属中山医院 | 一种特异性结合甲胎蛋白核酸适配体的筛选方法 |
CN104597246A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 |
CN104360085A (zh) * | 2014-12-05 | 2015-02-18 | 重庆乾德生物技术有限公司 | 一种afp检测试剂盒 |
CN104931478A (zh) * | 2015-06-11 | 2015-09-23 | 江南大学 | 基于银纳米粒子三聚体的表面增强拉曼散射效应超灵敏检测甲胎蛋白的方法 |
Non-Patent Citations (3)
Title |
---|
CHAO-JYUN HUANG ET AL.: "An integrated microfluidic system for rapid screening of alpha-fetoprotein-specific aptamers", 《BIOSENSORS AND BIOELECTRONICS》 * |
YOUNG JU LEE ET AL.: "Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 * |
朱旭东等: "SELEX技术与适体", 《生命的化学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106501226A (zh) * | 2016-10-17 | 2017-03-15 | 柳州立洁科技有限公司 | 利用兴奋剂核酸适体epo5的兴奋剂试剂盒及其检测方法 |
CN106525784A (zh) * | 2016-10-17 | 2017-03-22 | 柳州立洁科技有限公司 | 基于核酸适体荧光探针ins5胰岛素试剂盒及其检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107561285A (zh) | 2018-01-09 |
CN107561285B (zh) | 2019-03-22 |
CN107561286A (zh) | 2018-01-09 |
CN105785033B (zh) | 2017-10-31 |
CN107561284B (zh) | 2019-01-29 |
CN107576801A (zh) | 2018-01-12 |
CN107561284A (zh) | 2018-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103185713B (zh) | 用于上皮组织肿瘤细胞的检测剂组合物及其制备方法 | |
CN105606582A (zh) | 基于核酸适体荧光探针afp4的甲胎蛋白试剂盒及其检测方法 | |
CN104597246B (zh) | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 | |
Bosl et al. | Tumor markers in advanced nonseminomatous testicular cancer | |
CN105785033A (zh) | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 | |
CN105785034B (zh) | 基于核酸适体荧光探针afp3的甲胎蛋白试剂盒及其检测方法 | |
CN105603101A (zh) | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 | |
CN103782175A (zh) | 胰腺病标记物的检出方法 | |
CN106018829A (zh) | 一种血清淀粉样蛋白a的测定试剂及其制备方法 | |
CN107328942A (zh) | 一种荧光定量检测papp‑a的免疫层析试剂条及其制备方法 | |
Krier et al. | The asymptomatic outpatient with abnormal liver function tests | |
CN105651754A (zh) | 基于核酸适体荧光探针afp2的甲胎蛋白试剂盒及其检测方法 | |
CN105651755A (zh) | 基于核酸适体荧光探针afp1的甲胎蛋白试剂盒及其检测方法 | |
Aller et al. | Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography | |
CN103487587B (zh) | 老年痴呆症体外检测用检测板及其检测试剂盒 | |
Gruttadauria et al. | Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes | |
CN104597008B (zh) | 基于核酸适体荧光探针HCy3的同型半胱氨酸试剂盒及其检测方法 | |
CN104833663B (zh) | 基于核酸适体荧光探针的糖化血红蛋白试剂盒及其检测方法 | |
CN104597007B (zh) | 基于核酸适体荧光探针HCy5的同型半胱氨酸试剂盒及其检测方法 | |
CN106568750B (zh) | 一种基于荧光能量共振转移法的gfap检测方法 | |
CN106645053A (zh) | 基于高灵敏度核酸适体荧光探针ins3胰岛素试剂盒及其检测方法 | |
CN107190074B (zh) | hsa_circRNA_103127在唐氏综合征的诊断、治疗及预后中的应用 | |
CN106501226A (zh) | 利用兴奋剂核酸适体epo5的兴奋剂试剂盒及其检测方法 | |
CN107312836A (zh) | 小分子RNAmiRNA‑146a‑5p在相关疾病风险诊断中的应用 | |
US20140356861A1 (en) | Method for checking the self-healing process carried out by the immune system of a test subject infected with human papilloma virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Yongbiao Inventor before: Xu Dapeng |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170919 Address after: 528400 Guangdong province Zhongshan Nanlang Town Ho Chung Village of Southern China city science and technology park is a modern Chinese medicine plant No. one or two layer Applicant after: Zhongshan BGH Biotechnology Co.,Ltd. Address before: 535004 No. 1 Eagle Avenue, Qinzhou Port Economic Development Zone, the Guangxi Zhuang Autonomous Region, Qinzhou Applicant before: Xu Dapeng |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Alpha fetoprotein assay kit and detection method based on nucleic acid aptamer fluorescent probe AFP5 Effective date of registration: 20231208 Granted publication date: 20171031 Pledgee: Zhongshan Torch High-tech Industrial Development Zone Branch of Agricultural Bank of China Co.,Ltd. Pledgor: Zhongshan BGH Biotechnology Co.,Ltd. Registration number: Y2023980070122 |